Innovations in trapped ion mobility mass spectrometry and software give BioPharma scientists new tools to characterize biologic drugs with more speed and keep up with the pace of development. Mass spectrometry imaging is becoming an essential tool to understand diseases and determine drugs PK and metabolism which are essential to address the right tissue and evaluate toxicity early.
Poster 2023: Improved intact antibody characterization with a new ion source design
Poster 2023: Software enabled oligonucleotide mapping analysis of Erythropoietin mRNA
Poster 2023: Optimized CID conditions for 24-75 mer oligonucleotide MS/MS characterization
Poster 2023: Novel sample preparation platform coupled with LCMS for mRNA mass mapping
Poster 2022: Automated Annotation of Clipping Related Heterogeneities in Vedolizumab
Poster 2022: Glycosylation profiling of Cetuximab subunits with CZE-MS
Poster 2022: Differentiation of Isobaric 3‘- 5‘- Oligonucleotide Clipping Products by Trapped Ion Mobility Spectrometry
Poster 2022: Capillary Electrophoresis coupled to timsTOF Mass Spectrometry using nanoCEasy Interface
Poster 2021: A Simple and Sensitive Method to Extract Glycan Profiles from Peptide Mapping Data
Poster 2021: Automated rapid antibody screening with a UHR ESI QTOF Mass Spectrometer and BioPharma Compass®
Poster 2021: CCS-enabled drug metabolite profiling and characterization workflow for distinguishing drug metabolites
Poster 2021: Charge variant analysis of Cetuximab with Chip Based CZE-MS
Poster 2021: Drug metabolite analysis with Trapped Ion Mobility Mass Spectrometry and Mass-MetaSite high throughput data analysis
Poster 2021: Sequence Curation and Glycoform Analysis of SARS-CoV-2 RBD Domains Produced in Mammalian Cell Lines
Poster 2021: High Throughput Screening for Host Cell Proteins with sub ppm sensitivity using dia-PASEF® with a 15 minute gradient
Poster 2020: Integrated characterization and screening workflows to simplify the design of MAM methods
Poster 2020: Use of PASEF® for Accelerated Protein Sequence Confirmation and de novo Sequencing with High Data Quality
Poster 2020: Sensitive drug distribution measurements of an ADC with non-denaturing capillary SEC
Poster 2020: Enhanced detection of host cell proteins enabled by use of collisional cross section values
Poster 2020: Novel High-Throughput MALDI-TOF MS Workflow for Screening of Different Analytes at Each Position on a Plate
Poster 2020: Reproducibility of native SEC LC-MS intact mAb characterisation measurements
Poster 2020: Assaying Protein / Ligand Binding with High-Resolution Native Mass Spectrometry
Poster 2019: Structural study of a PEGylated therapeutic protein by MALDI-ISD and ESI-QTOF
Poster 2019: Streamlining mAb characterization with a PASEF® based disulfide analysis workflow
Poster 2019: Separation of Asp/IsoAsp Isobaric Peptides using Trapped Ion Mobility Spectrometry (TIMS)
Poster 2019: A software platform for the quality control of synthetic oligonucleotides
Poster 2019: Predicting Lymph Node Metastasis in Endometrial Cancer by multi-modal mass spectrometry imaging
Poster 2019: Mass Spectrometric In-Depth Proteome Analysis of the Kidneys from Rat Model of Diabetic Nephropathy
Poster 2019: Metabolomics Characterization of Cell Culture Media by Ultrahigh Resolution LC-QTOF-MS Analysis
Poster 2019: Analysis of Histones from HEK293 Cells using a QTOF with Trapped Ion Mobility and PASEF® Workflows
For Research Use Only. Not for use in clinical diagnostic procedures.